|4Jan 27, 12:59 PM ET

Corkrean John J 4

4 · FULLER H B CO · Filed Jan 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Fuller H.B. (FUL) CFO John Corkrean Exercises Options

What Happened

  • John J. Corkrean, Executive Vice President and Chief Financial Officer of Fuller H. B. Co. (FUL), exercised stock-based derivatives and received an equity award on Jan 24, 2026. He converted 4,244 derivative units into common shares (2,943 + 1,301) at $60.07 per share (total value $254,937) and was granted 116 shares at $60.07 (value $6,968). Gross value of shares acquired was $261,905.
  • To cover exercise costs and tax liabilities, 1,470 shares were surrendered/withheld (465 and 1,005 shares, total value $88,303). Net new shares received after withholding: 2,890.

Key Details

  • Transaction date: 2026-01-24; filing date: 2026-01-27.
  • Prices: $60.07 per share for all reported items.
  • Specifics: Exercised derivatives (code M) for 2,943 and 1,301 shares; award/grant (code A) of 116 shares; shares withheld to pay exercise price/taxes (code F) of 465 and 1,005 shares.
  • Footnotes: F2 and F3 indicate shares were withheld to satisfy tax obligations on issued shares. Other footnotes on the filing describe dividend-equivalent treatment and conversion mechanics for deferred/awarded units.
  • Shares owned after the transaction are not specified in the provided summary of the filing; net increase from these events is 2,890 shares (4,360 acquired minus 1,470 withheld).

Context

  • These transactions reflect exercising company awards and an award grant, not an open-market purchase or a sale to diversify holdings. The withholding of shares to cover taxes/exercise costs is a common, non-cash way executives satisfy tax liabilities (often called a cashless or share-withholding method).
  • Derivative “disposed” lines in the filing reflect the cancellation/conversion of the exercised options. The filing was submitted on Jan 27, 2026; no late-filing indication is noted in the record provided.

Insider Transaction Report

Form 4
Period: 2026-01-24
Corkrean John J
Executive VP and CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-24$60.07/sh+2,943$176,78657,589 total
  • Exercise/Conversion

    Common Stock

    2026-01-24$60.07/sh+1,301$78,15158,890 total
  • Award

    Common Stock

    [F1]
    2026-01-24$60.07/sh+116$6,96859,006 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-24$60.07/sh465$27,93358,541 total
  • Tax Payment

    Common Stock

    [F3]
    2026-01-24$60.07/sh1,005$60,37057,536 total
  • Exercise/Conversion

    Performance Stock Units

    [F4]
    2026-01-24$60.07/sh2,943$176,7860 total
    Exercise: $0.00From: 2026-01-24Exp: 2026-01-24Common Stock (2,943 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F5][F6]
    2026-01-24$60.07/sh1,301$78,1510 total
    Exercise: $0.00From: 2024-01-24Exp: 2026-01-24Common Stock (1,301 underlying)
Holdings
  • Employee Stock Option (Right-to-Buy)

    [F7]
    Exercise: $45.05From: 2020-01-24Exp: 2029-01-24Common Stock (41,208 underlying)
    41,208
  • Employee Stock Option (Right-to-Buy)

    [F7]
    Exercise: $48.35From: 2021-01-24Exp: 2030-01-24Common Stock (48,309 underlying)
    48,309
  • Employee Stock Option (Right-to-Buy)

    [F7]
    Exercise: $50.10From: 2018-01-26Exp: 2027-01-26Common Stock (23,696 underlying)
    23,696
  • Employee Stock Option (Right-to-Buy)

    [F7]
    Exercise: $51.89From: 2022-01-27Exp: 2031-01-27Common Stock (38,376 underlying)
    38,376
  • Employee Stock Option (Right-to-Buy)

    [F7]
    Exercise: $53.57From: 2019-01-25Exp: 2028-01-25Common Stock (21,834 underlying)
    21,834
  • Employee Stock Option (Right-to-Buy)

    [F8]
    Exercise: $64.28From: 2026-01-27Exp: 2035-01-27Common Stock (24,570 underlying)
    24,570
  • Employee Stock Option (Right-to-Buy)

    [F7]
    Exercise: $68.17From: 2024-01-24Exp: 2033-01-24Common Stock (22,312 underlying)
    22,312
  • Employee Stock Option (Right-to-Buy)

    [F7]
    Exercise: $72.94From: 2023-01-24Exp: 2032-01-24Common Stock (21,997 underlying)
    21,997
  • Employee Stock Option (Right-to-Buy)

    [F8]
    Exercise: $77.72From: 2025-01-26Exp: 2034-01-26Common Stock (24,774 underlying)
    24,774
  • Phantom Units

    [F9][F10][F11]
    Exercise: $0.00Common Stock (28,248.05 underlying)
    28,248.05
  • Restricted Stock Units

    [F5][F6][F12]
    Exercise: $0.00From: 2025-01-26Exp: 2027-01-26Common Stock (2,852.64 underlying)
    2,852.64
  • Restricted Stock Units

    [F5][F6][F12]
    Exercise: $0.00From: 2026-01-27Exp: 2028-01-27Common Stock (4,370.58 underlying)
    4,370.58
Footnotes (12)
  • [F1]This amount reflects the number of shares acquired pursuant to dividend accruals during the vesting period.
  • [F10]These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
  • [F11]Amount includes stock units acquired pursuant to a dividend equivalent feature.
  • [F12]Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
  • [F2]Shares withheld for taxes due on 1,301 shares issued.
  • [F3]Shares withheld for taxes due on 3,059 shares issued.
  • [F4]These performance stock units convert into shares of common stock on a 1-for-1 basis.
  • [F5]These restricted stock units convert into shares of common stock on a 1-for-1 basis.
  • [F6]These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F7]This option is 100% vested.
  • [F8]This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F9]These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
Signature
/s/ Patrick J. Seul, Attorney-in-Fact|2026-01-27

Documents

1 file
  • 4
    doc4.xmlPrimary